51 related articles for article (PubMed ID: 305255)
1. Tumor propagating cells: drivers of tumor plasticity, heterogeneity, and recurrence.
Vessoni AT; Filippi-Chiela EC; Lenz G; Batista LFZ
Oncogene; 2020 Mar; 39(10):2055-2068. PubMed ID: 31801972
[TBL] [Abstract][Full Text] [Related]
2. Acid alpha-naphthyl acetate esterase activity in human neoplastic lymphoid cells. Usefulness as a T-cell marker.
Knowles DM; Halper JP; Machin GA; Sherman W
Am J Pathol; 1979 Jul; 96(1):257-77. PubMed ID: 313712
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte migration in malignant disease.
Crowther D; Wagstaff J
Clin Exp Immunol; 1983 Mar; 51(3):413-20. PubMed ID: 6342879
[TBL] [Abstract][Full Text] [Related]
4. Criteria for involvement of lymph node, bone marrow, spleen, and liver in Hodgkin's disease.
Lukes RJ
Cancer Res; 1971 Nov; 31(11):1755-67. PubMed ID: 4941351
[No Abstract] [Full Text] [Related]
5. The T and B lymphocyte content of lymph nodes and spleen in Hodgkin's disease.
Stathopoulos G; Papamichail M; Peckham MJ; Davies AJ; Holborow EJ
Br J Exp Pathol; 1977 Dec; 58(6):712-6. PubMed ID: 305255
[TBL] [Abstract][Full Text] [Related]
6. T and B lymphocytes in lymph nodes and spleen of patients with Hodgkin's disease.
Berényi E; Sonkoly I; Pálóczi K; Balázs G; Szegedi G
Neoplasma; 1979; 26(3):307-13. PubMed ID: 394011
[TBL] [Abstract][Full Text] [Related]
7. T and B lymphocytes and Reed-Sternberg cells in Hodgkin's disease lymph nodes and spleens.
Payne SV; Jones DB; Haegert DG; Smith JL; Wright DH
Clin Exp Immunol; 1976 May; 24(2):280-6. PubMed ID: 1084241
[TBL] [Abstract][Full Text] [Related]
8. SPLEEN/PATHOL.
Bukowski RM; Noguchi S; Hewlett JS; Deodhar S
Am J Clin Pathol; 1976 Jan; 65(1):30-9. PubMed ID: 1082240
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte subpopulations of lymph nodes and spleens in Hodgkin's disease.
Pinkus GS; Barbuto D; Said JW; Churchill WH
Cancer; 1978 Sep; 42(3):1270-9. PubMed ID: 308838
[No Abstract] [Full Text] [Related]
10. [Proportion of B- and T-lymphocytes in lymph nodes removed from patients with Hodgkin's disease].
Pluzzańska A; Robak T; Szadowska A; Kabza R; Tume Z; Maciejczyk J; Mazurowa A
Acta Haematol Pol; 1978; 9(1):19-24. PubMed ID: 307324
[TBL] [Abstract][Full Text] [Related]
11. The thymic origin of Hodgkin's disease.
THOMSON AD
Br J Cancer; 1955 Mar; 9(1):37-50. PubMed ID: 14378492
[No Abstract] [Full Text] [Related]
12. Proliferation characteristics of the various classes of cells in Hodgkin's disease.
Peckham MJ; Cooper EH
Cancer; 1969 Jul; 24(1):135-46. PubMed ID: 5790284
[No Abstract] [Full Text] [Related]
13. Significance of the changes in the circulating lymphoid cells in Hodgkin's disease.
Cowther D; Fairley GH; Sewell RL
Br Med J; 1969 May; 2(5655):473-7. PubMed ID: 5771577
[TBL] [Abstract][Full Text] [Related]
14. Delayed hypersensitivity in Hodgkin's disease. A study of 103 untreated patients.
Young RC; Corder MP; Haynes HA; DeVita VT
Am J Med; 1972 Jan; 52(1):63-72. PubMed ID: 5058359
[No Abstract] [Full Text] [Related]
15. In vitro lymphocyte response to phytohemagglutinin and pokeweed mitogen in Hodgkin's disease. An electron microscopic and functional study.
Cohnen G; Douglas SD; König E; Brittinger G
Cancer; 1973 Jun; 31(6):1346-53. PubMed ID: 4709951
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
